Long-acting medicines for malaria, tuberculosis and hepatitis C
View More
Unitaid-funded projects develop innovative medicines, diagnostic tools and public health techniques and link them quickly, and at affordable prices, to those most in need.
Our grant projects apply the best that science has to offer to the fight against HIV and co-infections, tuberculosis and malaria in lower-resource countries.
Grant focus
To develop long-acting formulations of key medicines and create a market for them
Grantees
University of Liverpool
Status
Current
Amount
US$ 32,004,459
Disease
Hepatitis C, HIV and Co-Infection, Malaria, Tuberculosis
View More
Grant focus
The IMPACT project seeks to interrupt malaria transmission
Grantees
MedinCell
Status
Current
Amount
US$ 6,358,125
Disease
Malaria
View More
Grant focus
To provide equitable access to appropriate Plasmodium vivax treatment options and reduce the global disease burden by accelerating target country adoption of radical cure tools
Grantees
Medicines for Malaria Venture (MMV)
Status
Current
Amount
US$ 24,950,980
Disease
Malaria
View More
Grant focus
To equip primary health care workers with easy-to-use devices so they can better identify severely ill children and refer them for treatment.
Grantees
PATH
Status
Current
Amount
US$ 28,442,480
Disease
Malaria
View More
Grant focus
To pilot long-lasting nets treated with new insecticide combinations in sub-Saharan African countries hardest hit by malaria
Grantees
Innovative Vector Control Consortium (IVCC)
Status
Complete
Amount
US$ 66,000,000 *
Disease
Malaria
View More
Grant focus
To evaluate the mass-distribution of ivermectin to humans and livestock in two African countries during the malaria season.
Grantees
Barcelona Institute for Global Health (ISGlobal)
Status
Current
Amount
US$ 25,316,950
Disease
Malaria
View More
Grant focus
To evaluate slow-release repellents that drive mosquitoes from inhabited areas
Grantees
University of Notre Dame
Status
Current
Amount
US$ 33,724,865
Disease
Malaria
View More
Grant focus
Overcome barriers to availability, quality and supply of medicines for severe malaria and malaria prevention
Grantees
Medicines for Malaria Venture (MMV)
Status
Current
Amount
US$ 3,361,023
Disease
Malaria
View More